Revised USP Chapter 467 and its Application to Excipient Qualification and Testing (TN-2032)

Abstract:

All pharmaceutical companies need to determine as soon as possible how the changes to General Chapter <467> will impact their testing procedure. The more excipients and vendors a company uses, the more difficult it will be to demonstrate compliance with the new methodology.

Document Type:

Technical Notes

Industries:

Pharmaceutical/Biopharmaceutical

Techniques:

GC

Brands:

Zebron

PDF Link:

Click here